Lessons from the cardiac arrhythmia suppression trial.
Garratt
C
C
Department of Cardiological Sciences, St George's Hospital Medical School, London.
Ward
D E
DE
Camm
A J
AJ
D000813:Anilides / Q000009:adverse effects* / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D016700:Encainide; D005424:Flecainide / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D016293:Moricizine; D009203:Myocardial Infarction / Q000150:complications; D010640:Phenothiazines / Q000627:therapeutic use; D014481:United States
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D010640:Phenothiazines; D016293:Moricizine; D005424:Flecainide; D016700:Encainide